Testing a new drug for insomnia
Part of Brain & nervous system, Mental health clinical trials.
This trial tests a new medication, APSTZD, to see how well it works and how safe it is for people with insomnia, especially those who have trouble staying asleep through the night.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 64 years old.
- You have been diagnosed with insomnia and struggle to stay asleep during the night.
- You agree not to drink any alcohol for the entire 6 weeks of treatment.
- You have not had any problems with alcohol or drug abuse in the past 2 years.
- You are not pregnant, breastfeeding, or planning to become pregnant during the trial.
- You do not have severe liver disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a part of the brain called the locus coeruleus is involved in insomnia. It involves sleep questionnaires and possibly brain imaging to understand your sleep problems better.
This trial tests if a sleep therapy using anesthesia can help people with long-term insomnia that hasn't improved with other treatments. It aims to improve sleep and daytime symptoms like mood or concentration problems.
This study compares how well different over-the-counter and prescription sleep medications work for insomnia. Researchers will guide you through trying medications one at a time to find what works best for your sleep problems.
This trial tests a new sleep therapy called PROSOMNIA Sleep Therapy™ for people who have trouble sleeping (chronic insomnia, sleep deprivation, or poor sleep quality) and haven't found relief with current treatments. The therapy involves a brief anesthesia, so it's only for people who are healthy enough to safely receive anesthesia.
This study tests an experimental insomnia drug called dimdazenil in people with Parkinson's disease who also have trouble sleeping. It aims to see if the drug can improve sleep without causing new side effects.
This study tests a new approach called 'paradoxical intention' for treating insomnia. Instead of trying to force sleep, you will learn to stay awake, which may reduce the anxiety that makes it hard to fall asleep. The trial aims to see if this method works and how people experience it.
Hear when a new Insomnia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.